"10.1371_journal.pone.0133970","plos one","2015-08-19T00:00:00Z","Erik Tandberg Askevold; Lars Gullestad; Ståle Nymo; John Kjekshus; Arne Yndestad; Roberto Latini; John G F Cleland; John J V McMurray; Pål Aukrust; Thor Ueland","Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway; K. G. Jebsen Cardiac Research Centre and Center for Heart Failure Research, Oslo, Norway; K. G. Jebsen Inflammatory Research Center, Oslo, Norway; K. G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway; IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy; Department of Cardiology, Hull York Medical School, University of Hull, Castle Hill Hospital, Kingston-upon-Hull, United Kingdom; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom","Conceived and designed the experiments: ETA PA TU SN. Performed the experiments: ETA TU. Analyzed the data: ETA TU SN. Contributed reagents/materials/analysis tools: TU PA RL LG JK JGFC JJVM AY. Wrote the paper: ETA TU PA LG.","John Kjekshus and John J. V. McMurray have received consulting or advisory board fees from AstraZeneca. John Kjekshus, John J. V. McMurray, John G. F. Cleland and Lars Gullestad have received lecture fees from AstraZeneca. John J. V. McMurray has received research grants from AstraZeneca. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","08","Erik Tandberg Askevold","ETA",10,TRUE,4,2,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
